Drug Detail

Drug Name AZD6738
Trade Name
Drug Descriptions

AZD6738 is an inhibitor of ATR, which may enhance the sensitivity of chemotherapeutic agents, potentially resulting in tumor regression (PMID: 26517239).

DrugClasses ATR Inhibitor 10


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Acalabrutinib + AZD6738 AZD6738 Acalabrutinib 0 1
AZD6738 AZD6738 0 3
AZD6738 + Carboplatin AZD6738 Carboplatin 0 1
AZD6738 + Cisplatin AZD6738 Cisplatin 2 0
AZD6738 + Durvalumab AZD6738 Durvalumab 0 2
AZD6738 + Ibrutinib AZD6738 Ibrutinib 2 0
AZD6738 + Olaparib AZD6738 Olaparib 1 6
AZD6738 + Paclitaxel AZD6738 Paclitaxel 1 0
AZD6738 + Radiotherapy AZD6738 Radiotherapy 4 0

Additional content available in CKB BOOST